Anabel Costa-Ferreira

London

Reporter at Norstella

Writer at In Vivo

Featured in: Favicon

citeline.com Favicon

norstella.com Favicon

thisislocallondon.co.uk Favicon

informa.com (+2) Favicon

exepose.com Favicon

invivo.citeline.com

Articles

Global Pharma Guidance Tracker - March 2025

2 weeks ago | insights.citeline.com | Vibha Sharma |Anabel Costa-Ferreira
Landmark Pilot Paves Way for Faster Drug Approvals In Africa

3 weeks ago | insights.citeline.com | Anabel Costa-Ferreira

Landmark Pilot Paves Way for Faster Drug Approvals In Africa In a historic move for Africa, five products have been backed for approval via a pilot that tested a continental listing process. • Source: African Medicines Regulatory Harmonization (AMRH)
RESILIENCE Initiative Navigates The World Of Making Medicines Through VR Technology

3 weeks ago | insights.citeline.com | Anabel Costa-Ferreira

RESILIENCE Initiative Navigates The World Of Making Medicines Through VR Technology The process of manufacturing medicines can often be complex, expensive and harmful to the environment. Initiatives like RESILIENCE UK are seeking to simplify this process, utilizing VR technology to create a more sustainable learning environment for both students and companies. Bioreactor in the UCL Manufacturing Futures Laboratory (as then shown through the VR headset).
Podcast: Heranova CMO Advocates For Endometriosis Awareness: “Pain Is Not Normal”

3 weeks ago | insights.citeline.com | Anabel Costa-Ferreira

Podcast: Heranova CMO Advocates For Endometriosis Awareness: “Pain Is Not Normal”Farideh Bischoff, chief medical officer of Heranova Lifesciences, discusses the urgent need for better diagnostic options and the latest innovations transforming care for endometriosis patients.
Eisai Still Considering Next Steps After Australia Again Rejects Alzheimer’s Drug Leqembi

1 month ago | insights.citeline.com | Anabel Costa-Ferreira

Eisai Still Considering Next Steps After Australia Again Rejects Alzheimer’s Drug Leqembi The Australian Therapeutic Goods Administration proposed a narrower indication that Eisai rejected. Eisai to continue seeking a path for Australians to access Leqembi (Shutterstock)
Global Pharma Guidance Tracker - February 2025

1 month ago | insights.citeline.com | Vibha Sharma |Anabel Costa-Ferreira

Global Pharma Guidance Tracker – February 2025Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Infographic: Analyzing The Gap In Women’s Health Care

1 month ago | insights.citeline.com | Anabel Costa-Ferreira

Infographic: Analyzing The Gap In Women’s Health CareLooking at a recent McKinsey report alongside our Evaluate data, the below infographic provides insight into the investment scene of pharma and raises questions as to how the industry is seemingly yet to seize the opportunity in women's health.
Micron’s Peel & Stick Device Offers Hope For Needle-Free Drug Administration

1 month ago | insights.citeline.com | Anabel Costa-Ferreira

Micron’s Peel & Stick Device Offers Hope For Needle-Free Drug AdministrationSteven Damon, Micron Biomedical CEO, discusses the promising future of Micron’s microneedle technology, which allows for painless vaccine delivery through pressing a small patch onto the skin.
Quotables: Pharma Leaders On The Month’s Hot Topics

1 month ago | insights.citeline.com | Anabel Costa-Ferreira

Quotables: Pharma Leaders On The Month’s Hot TopicsThe highlights of recent comments and insights from industry executives on the key issues covered in Scrip. Source- Shutterstock (Shutterstock)
Podcast: JPM Tracked And Unpacked

2 months ago | insights.citeline.com | Anabel Costa-Ferreira

Podcast: JPM Tracked And Unpacked In the latest episode of the In Vivo podcast, Citeline’s expert panel of reporters and analysts unpack the biggest deals, trends and innovations following the J.P. Morgan Healthcare Conference.